Testbed for clinical studies that facilitate the introduction of more accurate prevention and treatment in cancer care.
The research institute SIR at the Stockholm School of Economics is the coordinator for the innovation environment with participating regions, academia, authorities, industry and patient associations.
The initiators are Nollvision Cancer, Genomic Medicine Sweden and SciLifeLab.
Support from Swelife and Vinnova
SEK 16,000,000
Principal applicant organization
Foundation Stockholm School of Economics (SSE) – Foundation Stockholm School of Economics SIR
Time frame
October 2021 – September 2026
Contact
Ebba Hallersjö Hult
ebba.hallersjo.hult@hhs.se